Drugmaker Teva has announced that the U.S. Food and Drug Administration has approved its generic form of the pain patch Duragesic for sale in the United States. According to a Teva press release, the generic--called the Fentanyl Transdermal System--will be available in 25 mcg/hour, 50 mcg/hour, 75 mcg/hour, and 100 mcg/hour dosages. Teva said they will begin shipping the generic pain patch immediately.
Read moreWhile fentanyl patches can be very effective for relieving chronic pain, sometimes keeping them from falling off presents quite a... Read more »
The FDA reports that PriCara and Sandoz, Inc. have announced a voluntary nationwide recall of all lots of 25 mcg/hr Duragesic Patches... Read more »
Because the FDA continues to receive reports of death and life-threatening side effects in patients who use the fentanyl patch (brand name:... Read more »
Two weeks ago we told you that the 25mcg/hr fentanyl transdermal system patches (also known as Duragesic patches) were being recalled due... Read more »
Question: I have been living with RA since 1991. For the last 5-6 years I have been on Vicodin of various strengths. The Vicodin no longer... Read more »
Phase II clinical trials have begun on a pain patch that's designed to give chronic-pain sufferers seven days of pain relief. The new trials on the... Read more »
There are no specific medications made for TMJ disorder, so drugs can only be prescribed to treat the symptoms. Symptoms of TMJ disorder vary... Read more »
Source: Breastcancer.org
Numbness is a loss of feeling in an area of your body. You don't feel touch, temperature, or pain. Numbness can be caused by nerve damage or... Read more »